# Adherence in Patients Receiving PegIntron Pen/Rebetol for Hepatitis C in Conjunction With a Patient Assistance Program (Study P04281)(COMPLETED)

> **NCT00704522** · — · COMPLETED · sponsor: **Merck Sharp & Dohme LLC** · enrollment: 601 (actual)

## Conditions studied

- Hepatitis C, Chronic
- Hepacivirus

## Interventions

- **BIOLOGICAL:** Peginterferon alfa-2b (SCH 54031)
- **DRUG:** Ribavirin (SCH 18908)
- **BEHAVIORAL:** Patient assistance program

## Key facts

- **NCT ID:** NCT00704522
- **Lead sponsor:** Merck Sharp & Dohme LLC
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2005-03
- **Primary completion:** 2009-04
- **Final completion:** 2009-04
- **Target enrollment:** 601 (ACTUAL)
- **Last updated:** 2015-10-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00704522

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00704522, "Adherence in Patients Receiving PegIntron Pen/Rebetol for Hepatitis C in Conjunction With a Patient Assistance Program (Study P04281)(COMPLETED)". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT00704522. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*